
Biocon Biologics Scores EC Approval for Biosimilar to Ustekinumab
India-based Biocon Biologics, a biosimilars company and subsidiary of Biocon Ltd, has been granted marketing authorization in the European Union (EU) by the European Commission (EC) for its biosimilar ustekinumab product (brand name YESINTEK), referencing …